Trading CenturyFrom skin cancer to diabetes are a thing of the past.
| Revolution in Genetic Medicine | Imagine a world where 6,000 genetic diseases… From skin cancer to diabetes are a thing of the past. That's what President Trump envisioned within days of taking office… By signing "Executive Order 13771." To spearhead what 60 Minutes and the Nobel Laureate Committee have hailed as "the most consequential discovery in biomedicine this century" and the "Holy Grail" of medicine. Now, this is not just a distant dream. The UK's recent approval of a CRISPR-based therapy… Targeting sickle-cell disease and β-thalassaemia, marks a monumental step… In realizing this vision. This gene-editing technology, capable of altering the DNA in blood-producing stem cells… Offers a glimpse into a future where genetic diseases are effectively cured. Yet, with Biden's repeal of this executive order… What will it mean for the future of such groundbreaking medical advancements? Are we stepping back from a technology that could create more millionaires than any other in history? Click Here to Uncover the Full Story >> Stay informed, Simmy Adelman Editor, Behind the Markets | | | TheInvestingBenefits.com 2840 Fairfax St Suite 200 Denver, CO, 80207, United States A special message from the Editor of The Investing Benefits: We are often approached by other businesses with special offers for our readers. While many don’t make the cut, the message above is one we believe deserves your consideration. This offer is brought to you by The Investing Benefits. 600 N Broad St Ste 5 PMB 1, Middletown, DE 19709. If you would like to unsubscribe from receiving offers brought to you by The Investing Benefits click here. This еditorial email with educational nеws was sent to [email protected]. The Investing Benefits brought to you by Inception Media, LLC. If you have any questions regarding this email you can contact us here [email protected] 600 N Broad St Ste 5 PMB 1, Middletown, DE 19709 Inception Media, LLC. Аll rights reserved. Unsubscribe to stoр receiving mаrketing communication from us. Update Profile | |
|
|
|
|
|